Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- Check4 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page's footer revision tag changed from v3.2.0 to v3.3.1; this is a minor metadata update and does not affect content or features.SummaryDifference0.1%

- Check18 days agoChange DetectedRemoved a government funding status notice that stated potential delays; core study information such as title, conditions, locations, and outcomes remains unchanged.SummaryDifference0.4%

- Check32 days agoChange DetectedThe latest screenshot shows cosmetic/layout updates to the study page, with sections and navigation reorganized but all substantive content (dates, enrollment, inclusion/exclusion criteria, outcomes, and locations) remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a prominent government funding status notice and an updated version tag (v3.2.0) while removing the old version tag (v3.1.0).SummaryDifference4%

- Check68 days agoChange DetectedUpdated the page from revision v3.0.2 to v3.1.0, signaling a new release version.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.